Variability of gait speed during six minutes walking test in COPD and cystic fibrosis patients

Gait and Posture

Volumn 49, Issue , 2016, Pages 36-40

  Reychler, Gregory ^a,b,c   Debatisse, Margaux ^c   Lebecque, Patrick ^a,b   Pieters, Thierry ^a,b   Liistro, Giuseppe ^a,b   Gohy, Sophie ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Haute Ecole Leonard de Vinci   (Belgium)

Author keywords

Exercise tolerance; Respiratory; Speed; Walking

Indexed keywords

6 MINUTE WALKING TEST; ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WALKING SPEED; AGED; CLINICAL TRIAL; EXERCISE TEST; EXERCISE TOLERANCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TIME FACTOR; WALKING;

ADULT; AGED; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TIME FACTORS; WALKING; WALKING SPEED;

EID: 84975865865     PISSN: 09666362     EISSN: 18792219     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2016.06.007     Document Type: Article

References (37)

1. van de Weert-van Leeuwen P.B., Slieker M.G., Hulzebos H.J., Kruitwagen C.L., van der Ent C.K., Arets H.G. Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur. Respir. J. 2012, 39:893-898.
2. Troosters T., Demeyer H., Hornikx M., Camillo C.A., Janssens W. Pulmonary rehabilitation. Clin. Chest Med. 2014, 35:241-249.
3. Troosters T., Vilaro J., Rabinovich R., Casas A., Barbera J.A., Rodriguez-Roisin R., Roca J. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2002, 20:564-569.
4. Guyatt G.H., Pugsley S.O., Sullivan M.J., Thompson P.J., Berman L., Jones N.L., Fallen E.L., Taylor D.W. Effect of encouragement on walking test performance. Thorax 1984, 39:818-822.
5. ATS statement: guidelines for the six-minute walk test, Am. J. Respir. Crit. Care Med. (2002); 166: 111-117.
6. Del Corral T., Percegona J., Seborga M., Rabinovich R.A., Vilaro J. Physiological response during activity programs using Wii-based video games in patients with cystic fibrosis (CF). J. Cyst. Fibros. 2014.
7. Kon S.S., Patel M.S., Canavan J.L., Clark A.L., Jones S.E., Nolan C.M., Cullinan P., Polkey M.I., Man W.D. Reliability and validity of 4-metre gait speed in COPD. Eur. Respir. J. 2013, 42:333-340.
8. DePew Z.S., Karpman C., Novotny P.J., Benzo R.P. Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Respir. Care 2013, 58:2113-2119.
9. Karpman C., DePew Z.S., LeBrasseur N.K., Novotny P.J. Benzo RP determinants of gait speed in COPD. Chest 2014, 146:104-110.
10. Kon S.S., Canavan J.L., Nolan C.M., Clark A.L., Jones S.E., Cullinan P., Polkey M.I., Man W.D. The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur. Respir. J. 2014, 43:1298-1305.
11. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., Durie P.R., Legrys V.A., Massie J., Parad R.B., Rock M.J., Campbell P.W. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 2008, 153:S4-S14.
12. Miller M.R., Crapo R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen O.F., Pellegrino R., Viegi G., Wanger J. General considerations for lung function testing. Eur. Respir. J. 2005, 26:153-161.
13. Lesser D.J., Fleming M.M., Maher C.A., Kim S.B., Woo M.S. Keens TG does the 6-min walk test correlate with the exercise stress test in children. Pediatr. Pulmonol. 2010, 45:135-140.
14. Cunha M.T., Rozov T., de Oliveira R.C., Jardim J.R. Six-minute walk test in children and adolescents with cystic fibrosis. Pediatr. Pulmonol. 2006, 41:618-622.
15. Carter R., Holiday D.B., Nwasuruba C., Stocks J., Grothues C. Tiep B 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003, 123:1408-1415.
16. Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., Gosselink R., Decramer M., Dupont L. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur. Respir. J. 2009, 33:99-106.
17. Amorim P.B., Stelmach R., Carvalho C.R., Fernandes F.L., Carvalho-Pinto R.M., Cukier A. Barriers associated with reduced physical activity in COPD patients. J. Bras. Pneumol. 2014, 40:504-512.
18. Butland R.J., Pang J., Gross E.R., Woodcock A.A., Geddes D.M. Two-, six-, and 12-minute walking tests in respiratory disease. Br. Med. J. (Clin. Res. Ed.) 1982, 284:1607-1608.
19. Casas A., Vilaro J., Rabinovich R., Mayer A., Barbera J.A., Rodriguez-Roisin R., Roca J. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005, 128:55-61.
20. Poulain M., Durand F., Palomba B., Ceugniet F., Desplan J., Varray A. Prefaut C 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003, 123:1401-1407.
21. Palange P., Forte S., Onorati P., Manfredi F., Serra P., Carlone S. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J. Appl. Physiol. 2000, 88:1715-1720.
22. Dogra A.C., Gupta U., Sarkar M., Padam A. Exercise-induced desaturation in patients with chronic obstructive pulmonary disease on six-minute walk test. Lung India 2015, 32:320-325.
23. Martin C., Chapron J., Hubert D., Kanaan R., Honore I., Paillasseur J.L., Aubourg F., Dinh-Xuan A.T., Dusser D., Fajac I., Burgel P.R. Prognostic value of six minute walk test in cystic fibrosis adults. Respir. Med. 2013, 107:1881-1887.
24. Agrawal M.B., Awad N.T. Correlation between six minute walk test and spirometry in chronic pulmonary disease. J. Clin. Diagn. Res. 2015, 9:OC01-OC04.
25. Mak V.H., Bugler J.R., Roberts C.M., Spiro S.G. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 1993, 48:33-38.
26. Takigawa N., Tada A., Soda R., Date H., Yamashita M., Endo S., Takahashi S., Kawata N., Shibayama T., Hamada N., Sakaguchi M., Hirano A., Kimura G., Okada C., Takahashi K. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir. Med. 2007, 101:561-567.
27. Saglam M., Vardar-Yagli N., Savci S., Inal-Inc, Calik-Kutukcu E., Arikan H., Coplu L. Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2015, 10:423-428.
28. Agrawal S.R., Joshi R., Jain A. Correlation of severity of chronic obstructive pulmonary disease with health-related quality of life and six-minute walk test in a rural hospital of central India. Lung India 2015, 32:233-240.
29. Wijkstra P.J., TenVergert E.M., van der Mark T.W., Postma D.S., van A.R., Kraan J., Koeter G.H. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994, 49:468-472.
30. Chetta A., Pisi G., Zanini A., Foresi A., Grzincich G.L., Aiello M., Battistini A., Olivieri D. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir. Med. 2001, 95:986-991.
31. Waatevik M., Johannessen A., Hardie J.A., Bjordal J.M., Aukrust P., Bakke P.S., Eagan T.M. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD 2012, 9:227-234.
32. Godding V., Stevens L., Lebecque P., Galanti L. Active and passive smoking by CF patients in Belgium: a national survey. Eur. Respir. J. 2012, 40.
33. Mannino D.M., Buist A.S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765-773.
34. Waterhouse J., Hudson P., Edwards B. Effects of music tempo upon submaximal cycling performance. Scand. J. Med. Sci. Sports 2010, 20:662-669.
35. Terwee C.B., Bot S.D., de Boer M.R., van der Windt D.A., Knol D.L., Dekker J., Bouter L.M., de Vet H.C. Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 2007, 60:34-42.
36. Chuang M.L., Lin I.F., Chen S.P. Kinetics of changes in oxyhemoglobin saturation during walking and cycling tests in COPD. Respir. Care 2014, 59:353-362.
37. Fiore C., Lee A., McDonald C., Hill C., Holland A. Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?. Chron. Respir. Dis. 2011, 8:181-184.